Pediatric Off-Patent Oncology Drug Studies To Be Discussed By Subcommittee
This article was originally published in The Pink Sheet Daily
Executive Summary
Post-marketing pediatric studies for approved oncologic products will also be a topic at the Oct. 20 meeting of the Pediatric Oncology Subcommittee.